Platelet count alterations associated with escitalopram, venlafaxine and bupropion in depressive patients

  • Hoo Rim Song
  • , Young Eun Jung
  • , Hee Ryung Wang
  • , Young Sup Woo
  • , Tae Youn Jun
  • , Won Myong Bahk

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Abstract

The objective of the present study was to evaluate changes in platelet counts on three different kinds of antidepressant. All subjects (n = 131) in their drug-naïve state had been diagnosed with depression. Escitalopram (n = 42), venlafaxine (n = 50) and bupropion (n = 39) were prescribed, and platelet count was measured before and after 1 month of treatment and compared. Decrease in platelet count on escitalopram was significant, while the others were not. These findings suggest that escitalopram may be associated with decreased platelet count, and bupropion is less likely to exert an influence on platelet count.

Original languageEnglish
Pages (from-to)457-459
Number of pages3
JournalPsychiatry and Clinical Neurosciences
Volume66
Issue number5
DOIs
StatePublished - Aug 2012

Keywords

  • bupropion
  • escitalopram
  • platelet count
  • venlafaxine

Fingerprint

Dive into the research topics of 'Platelet count alterations associated with escitalopram, venlafaxine and bupropion in depressive patients'. Together they form a unique fingerprint.

Cite this